January 24, 2023
Statement from Breakthrough T1D on the U.S. Food and Drug Administration (FDA) authorization of the Tidepool Loop:
January 24, 2023
Breakthrough T1D Kicks Off its 2023 TypeOneNation Summit Series with “January Jumpstart – Real World Tips for Exercise and Nutrition with Type 1 Diabetes”
January 23, 2023
Breakthrough T1D Mourns the Passing of Dr. Gerold Grodsky
January 17, 2023
Breakthrough T1D Mourns the Passing of Dr. Gerald Fishbone, 1934-2023
December 13, 2022
Breakthrough T1D Statement on Mark Cuban Cost Plus Drug Company Selling Low-Cost Insulin
December 6, 2022
NFL Stars Don Customized Cleats to Raise Awareness for Type 1 Diabetes
November 17, 2022
Breakthrough T1D Celebrates Tzield™ (teplizumab-mzwv) Approval
November 17, 2022
FDA Approves Tzield™ (teplizumab-mzwv)—a Drug that Can Delay the Onset of Type 1 Diabetes for Approximately 2 Years
November 7, 2022
Breakthrough T1D Moves the Type 1 Diabetes Community #ForwardAs1 in Recognition of National Diabetes Awareness Month
November 3, 2022
Breakthrough T1D Presents South Florida Resident John Cammett with the 2022 John Brady Award for Innovation
